PRO1107 / Genmab, ProfoundBio  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PRO1107 / Genmab
NCT06171789: PRO1107 in Patients With Advanced Solid Tumors

Recruiting
1/2
214
US
PRO1107
ProfoundBio US Co.
Endometrial Cancer, Ovarian Cancer, Triple Negative Breast Cancer, GastroEsophageal Cancer, Non-small Cell Lung Cancer, Urothelial Carcinoma
02/27
02/27

Download Options